SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon informs about Board meeting

07 Jul 2015 Evaluate

Biocon has informed that a meeting of the Board of Directors of the Company will be held on July 23, 2015, to approve and take on record the un-audited financial results for the quarter ended on June 30, 2015 (Q1). The Company will organize a conference call for analysts and investors on July 24, 2015. The details of the call will be available on the company’s website closer to the scheduled event.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

419.70 4.45 (1.07%)
30-Jun-2026 14:42 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1872.95
Dr. Reddys Labs. 1366.25
Cipla 1470.50
Zydus Lifesciences 1119.90
Lupin 2435.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: